A carregar...
Glucagon‐like peptide‐1 receptor agonists in the era of COVID‐19: Friend or foe?
The aim of the present manuscript is to discuss on potential pros and cons of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) as glucose‐lowering agents during COVID‐19 pandemic, and what is more to evaluate them as potential candidates for the treatment of patients, affected by COVID‐19 infect...
Na minha lista:
| Publicado no: | Clin Obes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995087/ https://ncbi.nlm.nih.gov/pubmed/33423388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cob.12439 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|